| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.029 | 36.376 | 39.553 | 47.785 | 59.484 | 62.509 | 60.994 | 70.836 | 87.742 | 112.264 |
| Total Income - EUR | 33.030 | 36.363 | 39.554 | 47.786 | 59.484 | 62.509 | 60.996 | 70.836 | 87.742 | 112.265 |
| Total Expenses - EUR | 16.250 | 32.951 | 16.545 | 12.885 | 14.108 | 13.143 | 14.437 | 16.538 | 34.345 | 22.266 |
| Gross Profit/Loss - EUR | 16.780 | 3.412 | 23.008 | 34.901 | 45.376 | 49.366 | 46.559 | 54.298 | 53.397 | 89.999 |
| Net Profit/Loss - EUR | 16.042 | 3.047 | 22.613 | 34.427 | 44.781 | 48.908 | 46.022 | 53.675 | 52.625 | 87.136 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Matedoka Gen Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.662 | 5.231 | 5.142 | 5.048 | 4.950 | 4.856 | 5.344 | 5.120 | 4.880 | 4.722 |
| Current Assets | 349.162 | 276.129 | 241.043 | 188.024 | 215.817 | 241.675 | 270.119 | 165.918 | 212.762 | 303.930 |
| Inventories | 36.340 | 15.935 | 17.641 | 17.358 | 17.165 | 16.904 | 14.783 | 14.933 | 2.439 | 2.652 |
| Receivables | 307.936 | 259.507 | 188.439 | 118.560 | 117.628 | 131.995 | 126.478 | 150.967 | 209.767 | 293.984 |
| Cash | 4.886 | 687 | 34.962 | 52.106 | 81.023 | 92.776 | 128.857 | 19 | 556 | 7.293 |
| Shareholders Funds | 322.119 | 248.538 | 211.643 | 157.247 | 160.497 | 193.654 | 235.381 | 119.391 | 171.654 | 257.831 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.746 | 32.928 | 34.542 | 35.824 | 60.270 | 52.877 | 40.081 | 51.647 | 45.987 | 50.821 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Matedoka Gen Med Srl